From: Total dosage of gardenia fruit used by patients with mesenteric phlebosclerosis
 | non-MP (n = 42) | MP (n = 10) | P value |
---|---|---|---|
Age (year) | 58.2 ± 14.8 | 66.1 ± 9.1 | .1113a |
58.5 (16–86) | 67.5 (49–77) | ||
Sex (male/female) | 11/31 | 5/5 | .2509b |
BMI (kg/m2) | 22.5 ± 3.8 | 23.0 ± 2.3 | .7024a |
22.5 (16.0–31.4) | 22.8 (19.5–27.7) | ||
DM (yes/no) | 5/37 | 3/7 | .1710b |
HT (yes/no) | 14/28 | 6/4 | .1562b |
LDL-c (yes/no) | 19/23 | 7/3 | .2913b |
TG (yes/no) | 8/34 | 4/6 | .2125b |
Liver disease (yes/no) | 0/42 | 1/9 | .1923b |
Herbal medicine treatment | Â | Â | Â |
 Ambulatory visit (years) | 6.8 ± 4.3 | 13.9 ± 3.0 | .0001c |
6.3 (1.5–17.9) | 15.1 (6.5–16.3) | ||
 GF administration period (years) | 4.2 ± 3.7 | 11.1 ± 3.5 | .0001c |
3.1 (0.2–14.8) | 12.1 (1.5–15.9) | ||
 Cumulative dosage of GF (g) | 1319.7 ± 1077.7 | 8239.1 ± 3817.4 | < .0001c |
997.5 (54.0–4542.0) | 6539.0 (5379.0–15792.0) |